We are working together with IndieBio team to launch our company in the US market. This means we are receiving mentoring and input to improve our D2C and B2B2C business models according to our customers’ needs.

During this week we were participating in the KOWs (killer of the week) where we were able to show good results for which we were recognized. Among them our first sales in Spain and Argentina, and the first success stories that we achieved with our technology based on MicroRNAs.



Comments are closed

es_ESSpanish en_USEnglish